Harvey V. Fineberg, MD, PhD
JAMA. 2017;317(17):1717-1718. doi:10.1001/jama.2017.1869
In this Viewpoint, the former president of the Institute of Medicine discusses the importance of conflicts of interest to the integrity of the medical profession, and the importance of policies to manage conflicts of interest that are specific, clear, public, comprehensible, and fair.
Bernard Lo, MD; Deborah Grady, MD, MPH
JAMA. 2017;317(17):1719-1720. doi:10.1001/jama.2017.1872
This Viewpoint considers if conflict of interest (COI) is proportional to the size of financial payment or reward and how size and type of payment should be accounted for in attempts to manage COIs.
Matthew S. McCoy, PhD; Ezekiel J. Emanuel, MD, PhD
JAMA. 2017;317(17):1721-1722. doi:10.1001/jama.2017.2308
This Viewpoint argues that 鈥減otential鈥 conflicts of interest (COIs) are actual COIs that are effectively managed, and calls for clear terminology to describe the severity of COIs and how they are identified and managed.
Lisa Bero, PhD
JAMA. 2017;317(17):1723-1724. doi:10.1001/jama.2017.3854
This Viewpoint explores the differences between financial and nonfinancial conflicts of interest, the effects of both on research bias, and the importance of managing each in ways that reduce bias.
Allen S. Lichter, MD
JAMA. 2017;317(17):1725-1726. doi:10.1001/jama.2017.3191
This Viewpoint discusses the complexities of meaningful conflicts of interest, how they affect the integrity of the medical profession, and progress the profession has made in developing organizational responses to conflicts of interest.
Ross E. McKinney Jr, MD; Heather H. Pierce, JD, MPH
JAMA. 2017;317(17):1727-1728. doi:10.1001/jama.2017.3857
This Viewpoint argues that a successful approach to managing financial conflicts of interest would involve strategies to identify and manage bias more generally.
Philip A. Pizzo, MD; Thomas J. Lawley, MD; Arthur H. Rubenstein, MBBCH
JAMA. 2017;317(17):1729-1730. doi:10.1001/jama.2017.2573
This Viewpoint discusses the important role that leaders of academic medical centers (AMCs) play in fostering collaborations with industry while managing individual and institutional conflicts of interest (COI).
Jeffrey S. Flier, MD
JAMA. 2017;317(17):1731-1732. doi:10.1001/jama.2017.1751
In this Viewpoint the dean of Harvard Medical School surveys the multifaceted aspects of conflict of interest among medical school faculty and urges a conflict-of-intererst research program to ensure objective and effective management of inevitable conflicts
Diane B. Wayne, MD; Marianne Green, MD; Eric G. Neilson, MD
JAMA. 2017;317(17):1733-1734. doi:10.1001/jama.2017.2079
This Viewpoint argues for the importance of medical school curricula and policies that educate students about conflicts of interest, their consequences, and how to manage them.
Sandro Galea, MD, DrPH; Richard Saitz, MD, MPH
JAMA. 2017;317(17):1735-1736. doi:10.1001/jama.2017.1659
This Viewpoint considers when extramural funding might represent a conflict of interest for schools of public health and suggests approaches for managing institutional conflicts of interest.
Steven E. Nissen, MD
JAMA. 2017;317(17):1737-1738. doi:10.1001/jama.2017.2516
This Viewpoint reviews relationships that professional medical associations (PMAs) can develop with commercial entities, the effects of conflicts of interest on PMA activities, including development of practice guidelines, and ways PMAs can prevent and manage adverse influences of those conflicts.
Harold C. Sox, MD
JAMA. 2017;317(17):1739-1740. doi:10.1001/jama.2017.2701
This Viewpoint proposes policies for managing conflicts of interest related to practice guideline development, including conflicts among guideline committee panelists and those that derive from guideline sponsors.
Barbara Barnes, MD, MS
JAMA. 2017;317(17):1741-1742. doi:10.1001/jama.2017.2981
This Viewpoint discusses conflicts of interest associated with continuing medical education and proposes strategies to address their influence on continuing medical education activities.
Katrina Armstrong, MD; Andrew A. Freiberg, MD
JAMA. 2017;317(17):1743-1744. doi:10.1001/jama.2017.2656
This Viewpoint discusses the need for physicians and hospitals to disclose relevant financial interests to patients and challenges to effective disclosure of those interests, and suggests principles that might guide effective policies for approaches to disclosure.
Ian Larkin, PhD; George Loewenstein, PhD
JAMA. 2017;317(17):1745-1746. doi:10.1001/jama.2017.2275
This Viewpoint considers how payment models for clinical services create conflicts of interest in medical practice and how a salary model of payment might diminish the conflict and have other benefits.
Abigail Zuger, MD
JAMA. 2017;317(17):1747-1748. doi:10.1001/jama.2017.2995
This Viewpoint discusses the challenges to fully informing patients about physician conflicts of interest (COIs) and questions if attempts to improve COI transparency will make a difference to and for patients.
Charles Ornstein, BA
JAMA. 2017;317(17):1749-1750. doi:10.1001/jama.2017.2613
This Viewpoint describes the US government鈥檚 Open Payments program and initiatives by ProPublica, a nonprofit investigative news program, all of which make information about physicians鈥 financial relationships with drug companies and associated prescribing habits free and accessible to the public.
Joanne Waldstreicher, MD; Michael E. Johns, MD
JAMA. 2017;317(17):1751-1752. doi:10.1001/jama.2017.4160
This Viewpoint discusses the conflicts of interest that arise from industry鈥檚 dual obligations to patients and shareholders and outlines progress academic medical centers and others have made managing conflicts of interest in industry-sponsored clinical research.
Robert Steinbrook, MD
JAMA. 2017;317(17):1753-1754. doi:10.1001/jama.2017.2477
This Viewpoint discusses whether payments to physicians for food and beverages from the pharmaceutical industry and other health care companies influence physicians鈥 drug prescribing behaviors.
Dariush Mozaffarian, MD, DrPH
JAMA. 2017;317(17):1755-1756. doi:10.1001/jama.2017.3456
This Viewpoint discusses the role of the food industry in funding nutrition research, the risk of bias in nutritional evidence arising from funders鈥 conflicts of interest (COIs), and actions recommended by the CDC to manage those COIs.
Julie D. Gottlieb, MA; Neil M. Bressler, MD
free access
JAMA. 2017;317(17):1757-1758. doi:10.1001/jama.2017.2207
This Viewpoint discusses the importance of high standards for editorial conflict of interest and suggests recusal procedures for editors that can help maintain the trust of readers.
Thomas J. Easley
free access
JAMA. 2017;317(17):1759-1760. doi:10.1001/jama.2017.3421
This Viewpoint discusses the role of publishers and editors in managing conflict of interest policies and practices for medical journals.
Joseph P. Thornton, JD
JAMA. 2017;317(17):1761-1762. doi:10.1001/jama.2017.4235
This Viewpoint discusses the duty of authors to report potential conflicts of interest, the legal and professional consequences of omissions, and processes for investigating allegations of failure to disclose conflicts of interest.